131 related articles for article (PubMed ID: 30003101)
1. Synergistic Effect of Endogenous and Exogenous Aldehydes on Doxorubicin Toxicity in Yeast.
Miles JS; Sojourner SJ; Whitmore AM; Freeny D; Darling-Reed S; Flores-Rozas H
Biomed Res Int; 2018; 2018():4938189. PubMed ID: 30003101
[TBL] [Abstract][Full Text] [Related]
2. Effects of metal ions and hydrogen peroxide on the phenotype of yeast hom6Δ mutant.
Tun NM; Lennon BR; O'Doherty PJ; Johnson AJ; Petersingham G; Bailey TD; Kersaitis C; Wu MJ
Lett Appl Microbiol; 2015 Jan; 60(1):20-6. PubMed ID: 25284025
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-related modifier pathway is a major determinant of doxorubicin cytotoxicity in Saccharomyces cerevisiae.
Huang RY; Kowalski D; Minderman H; Gandhi N; Johnson ES
Cancer Res; 2007 Jan; 67(2):765-72. PubMed ID: 17234788
[TBL] [Abstract][Full Text] [Related]
4. FKBP12 controls aspartate pathway flux in Saccharomyces cerevisiae to prevent toxic intermediate accumulation.
Arévalo-Rodríguez M; Pan X; Boeke JD; Heitman J
Eukaryot Cell; 2004 Oct; 3(5):1287-96. PubMed ID: 15470257
[TBL] [Abstract][Full Text] [Related]
5. Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill.
Schenk PW; Brok M; Boersma AW; Brandsma JA; Den Dulk H; Burger H; Stoter G; Brouwer J; Nooter K
Mol Pharmacol; 2003 Aug; 64(2):259-68. PubMed ID: 12869630
[TBL] [Abstract][Full Text] [Related]
6. Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines.
Brosseau N; Andreev E; Ramotar D
PLoS One; 2015; 10(7):e0133182. PubMed ID: 26177450
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in protection against doxorubicin-induced toxicity.
Injac R; Strukelj B
Technol Cancer Res Treat; 2008 Dec; 7(6):497-516. PubMed ID: 19044329
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Role of Human DNAJAs in the Response to Cytotoxic Chemotherapeutic Agents in a Yeast Model System.
Whitmore A; Freeny D; Sojourner SJ; Miles JS; Graham WM; Flores-Rozas H
Biomed Res Int; 2020; 2020():9097638. PubMed ID: 32149145
[TBL] [Abstract][Full Text] [Related]
9. Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation.
Forrest RA; Swift LP; Rephaeli A; Nudelman A; Kimura K; Phillips DR; Cutts SM
Biochem Pharmacol; 2012 Jun; 83(12):1602-12. PubMed ID: 22414726
[TBL] [Abstract][Full Text] [Related]
10. Effect of gene amplification on threonine production by yeast.
Farfán MJ; Martín-Rendón E; Calderón IL
Biotechnol Bioeng; 1996 Mar; 49(6):667-74. PubMed ID: 18626862
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae.
Xia L; Jaafar L; Cashikar A; Flores-Rozas H
Cancer Res; 2007 Dec; 67(23):11411-8. PubMed ID: 18056469
[TBL] [Abstract][Full Text] [Related]
12. Human DNA topoisomerase IIalpha-dependent DNA cleavage and yeast cell killing by anthracycline analogues.
Binaschi M; Farinosi R; Austin CA; Fisher LM; Zunino F; Capranico G
Cancer Res; 1998 May; 58(9):1886-92. PubMed ID: 9581829
[TBL] [Abstract][Full Text] [Related]
13. [Genotoxicity of doxorubicin assessed on Saccharomyces cerevisiae cell model].
Saenko IuV; Shutov AM
Eksp Klin Farmakol; 2007; 70(3):29-32. PubMed ID: 17650629
[TBL] [Abstract][Full Text] [Related]
14. Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.
Pearlman M; Jendiroba D; Pagliaro L; Keyhani A; Liu B; Freireich EJ; Travis E
Cancer Chemother Pharmacol; 2003 Dec; 52(6):477-81. PubMed ID: 12827292
[TBL] [Abstract][Full Text] [Related]
15. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Chewchuk S; Guo B; Parissenti AM
PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
[TBL] [Abstract][Full Text] [Related]
16. Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts.
Evig CB; Kelley EE; Weydert CJ; Chu Y; Buettner GR; Burns CP
Nitric Oxide; 2004 May; 10(3):119-29. PubMed ID: 15158691
[TBL] [Abstract][Full Text] [Related]
17. THE ROLE OF PROTEIN CHAPERONES IN THE SURVIVAL FROM ANTHRACYCLINE-INDUCED OXIDATIVE STRESS IN SACCHAROMYCES CEREVISIAE.
Miles JS; Sojourner SJ; Jaafar L; Whitmore A; Darling-Reed S; Flores-Rozas H
Int J Adv Res (Indore); 2018 Mar; 6(3):144-152. PubMed ID: 29657945
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
20. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
